• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

British boost for bird flu research

hawkeye

Well-known member
British boost for bird flu research

LONDON (AFP) - Fears of a deadly bird flu pandemic have prompted Britain's Medical Research Council (MRC) to boost its funding for studies into the virus, the body said.

The MRC has set aside more than six times the usual amount to assess the danger of the deadly H5N1 strain of the virus and to tackle a potential bird flu outbreak.

An extra 10 million pounds (14.7 million euros, 18.8 million dollars) has been allocated on top of the 1.6 million pounds normally set aside to look at the source, spread and potential cure for virus.

Avian influenza has infected millions of birds worldwide and killed at least 123 people, mostly in Asia, in recent years.

Ten research grants have already been awarded to "academically excellent and urgently needed" studies, said Professor Deborah Smith, the chair of the awards panel.

These include projects to understand how the flu virus targets human and bird cells; how H5N1 affects the immune system by studying patients in Vietnam; and research to improve the quality of new vaccine against the H5N1 strain.

Further grants are to be allocated.

"In the coming months, we will work with our partners to look again for gaps in research and consider how best to close them," Smith said.

"Once they've been identified, we'll invest in more research later this year and next in our effort to combat the threat from H5N1 on all fronts."

Calls for extra funding followed an MRC experts' mission to southeast Asia to discover more about the spread of bird flu.

The British government has also been under pressure to offset a possible future health crisis after the discovery in April of a dead swan on the Scottish coast. The bird had the H5N1 strain.

The MRC has set aside an additional 3.5 million pounds for flu research later in the year and a further five million pounds will be invested in 2007/08.
 
Re: British boost for bird flu research

WELLCOME TRUST SELLS FIRST BOND FROM UK CHARITY

LONDON (Reuters) - The Wellcome Trust on Thursday became the first UK charity to sell a public bond, raising 550 million pounds to boost the cash it invests to fund research spanning the human genome, bird flu and malaria.

The 30-year bond drew keen demand from sterling bond buyers, such as Britain's big pension funds and insurers, an official at one of the banks managing the sale said, allowing the Trust to increase the bond's size and trim the premium it pays over government debt.

The trust, the world's second-biggest charitable foundation funding biomedical research, said it received more than 1.1 billion pounds of orders from investors.

"We are delighted at the strong investor interest in the trust and are pleased to have secured additional long-term funding for the Trust and its charitable goals," Mark Walport, director of the Wellcome Trust, said in a statement.

The trust is borrowing at an annual rate of 4.721 percent, and is betting it can reap higher rewards in more exotic markets such as shares, property, hedge funds, and venture capital.

It will plough the bond's proceeds into its investment portfolio, which reached 12.3 billion pounds by end-September. Over the last 10 years it has made an average return of 9 percent, according to rating agency Standard & Poor's.

The bond, which pays a coupon of 4.625 percent, was sold at 98.469 percent of face value to yield 44 basis points over the benchmark 30-year government gilt, the trust said.

The spread is lower than earlier guidance for 45 to 48 basis points over gilts, and the bond is bigger than original guidance for 300 to 500 million pounds.

Barclays, JP Morgan Cazenove and Morgan Stanley managed the deal.

The Wellcome Trust's funding of biomedical research is topped only by Microsoft founder Bill Gates's Bill & Melinda Gates foundation, and Wellcome Trust-funded researchers sequenced one-third of the human genome.

Without direct comparisons for pricing, investors have compared Wellcome's deal to a range of instruments, from top-rated, wrapped asset-backed securities, to triple-A corporate borrowers such as GE, a banker familiar with the deal said on Monday.

Standard & Poor's and Moody's Investors Service have both assigned the bond, issued by Wellcome Trust Finance Plc, top triple-A credit ratings.

The Wellcome Trust was founded in 1936 by pharmaceuticals magnate Henry Wellcome and was the sole shareholder in his drugs company, The Wellcome Foundation Ltd, until 1986, when that went public. The drugs company is now part of GlaxoSmithKline, in which the Wellcome Trust holds a small stake.


Source: http://today.reuters.co.uk/news/new...l&pageNumber=0&imageid=&cap=&sz=13&WTModLoc=2
By Quentin Webb
Thu Jul 13, 2006 3:00 PM BST162
 
Re: British boost for bird flu research

SUPER COMPUTER TACKLES BIRD FLUE

A super computer, considered one of the most powerful in Europe, has been given a boost in its brain power for the UK?s fight against bird flu.
Blue C, based at Swansea University, has been made 20% more powerful so it can work out more quickly the best way to tackle a possible disease outbreak.

The flu?s H5N1 strain has killed 133 people worldwide and the UK had one confirmed case in a swan in April.

Blue C aims to predict where a UK outbreak would start.

By modelling bird flight patterns, experts hope the machine will work out how best to confine the disease, through culls and quarantines, should more birds carrying the disease migrate to the UK in future.

A spokeswoman for Swansea University said: ?The data government scientists are looking for to underline their decision is there to be found, that?s where Blue C is making the difference.

?Because of its processing power, it allows us to run multiple models throughout the system and means we?re waiting minutes or hours for the results.?

The project was funded by Defra, the rural affairs ministry, she added.

IBM-made Blue C, the size of a tennis court, is derived from Deep Blue, the first computer to beat a reigning world chess champion.

Energy bill

According to the university, the technology upgrade means Blue C now has a processing power of more than two teraflops - making over 2,000 million million operations per second.

Blue C is part of the university?s ?50m life sciences research centre, the research arm of the campus? School of Medicine.

A spokesperson for Swansea University said the computer?s upgrade has also cut the amount of power Blue C needs, making it a ?greener? machine and cutting its energy bill by ?50,000 year.

Professor Julian Hopkin, head of the school of medicine, said: ?The development of new medical breakthroughs demands vast computing power and Blue C has proved to be enormously important to our work here.?

Source: bird-flu-symptom.info/
Friday July 21st 2006, 11:59 pm
 
Back
Top